Wegovy vs Mounjaro: Mechanism, Dosing & Practical Differences
Understanding Wegovy vs Mounjaro: Core Mechanism Differences
The fundamental difference between Wegovy vs Mounjaro lies in their hormonal approach to weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics one natural fullness hormone, whilst Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors as a dual agonist. This means Mounjaro works on two hormone pathways simultaneously, potentially offering different appetite suppression patterns. Both are prescription-only medicines requiring clinical assessment, but their mechanisms may suit different patient profiles.
When comparing Wegovy vs Mounjaro for practical use, the dosing schedules differ significantly. Wegovy follows a 5-dose escalation from 0.25mg to 2.4mg maintenance over 16 weeks, whilst Mounjaro uses 6 doses ranging from 2.5mg to 15mg. Neither approach is inherently superior — your prescriber will consider your medical history, lifestyle factors, and previous treatment responses when recommending between these options. Both treatments require commitment to dietary changes and increased physical activity alongside the medication.
Wegovy vs Mounjaro Pricing: Transparent Cost Comparison
EverydayMeds offers competitive pricing for both Wegovy and Mounjaro, with clear cost structures for each treatment pathway. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with FIRST40 code for new customers), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our bundle options like the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99 provide convenient multi-month supplies. Returning customers can use code DOSE25 for ongoing treatment.
Mounjaro follows its own pricing structure, reflecting the different active ingredient and manufacturing processes. When evaluating Wegovy vs Mounjaro costs, consider the total treatment pathway rather than individual pen prices, as maintenance dosing requirements vary between treatments. Both options include next-day cold-chain delivery and prescriber review services. The choice between Wegovy vs Mounjaro shouldn't be based solely on initial pricing — clinical suitability and lifestyle factors are more important considerations for long-term weight management success.
Clinical Evidence: Wegovy vs Mounjaro Trial Data
Wegovy's clinical profile comes from the comprehensive STEP trial programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise interventions. The STEP 2 trial demonstrated effectiveness in patients with type 2 diabetes, whilst STEP 5 confirmed sustained benefits over 2 years. Recent SELECT trial data also showed 20% reduction in major cardiovascular events, published in Wilding et al., NEJM, 2021.
Mounjaro's evidence base derives from separate clinical trials using different methodologies and patient populations, making direct comparison of percentage weight loss inappropriate. When considering Wegovy vs Mounjaro, focus on which mechanism and dosing approach aligns with your clinical profile rather than comparing trial outcomes directly. Both treatments demonstrated significant weight management benefits in their respective studies, and both require ongoing commitment to lifestyle modifications for optimal results.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy's semaglutide works as a GLP-1 receptor agonist, mimicking the natural incretin hormone that signals fullness to the brain. This mechanism reduces appetite by acting on specific receptors in the hypothalamus, the brain region controlling hunger and satiety. The medication also slows gastric emptying, meaning food stays in the stomach longer, promoting sustained feelings of fullness after smaller meal portions. Additionally, Wegovy may help reduce food cravings and the psychological drive to eat, particularly for high-calorie foods. These combined effects support weight management when used alongside a reduced-calorie diet and increased physical activity, as the medication enhances natural satiety signals that may be diminished in people with obesity.
Ordering Process: Assessment to Delivery
Getting started with either Wegovy or Mounjaro through EverydayMeds follows our streamlined clinical pathway designed for patient safety and convenience. The process begins with a 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and previous treatment experiences. Our GPhC-registered prescribers (#9012878) review each application within 3 working days (24 hours with express service), determining clinical suitability based on MHRA licensing criteria and NICE guidelines. Once approved, your chosen treatment ships via next-day cold-chain delivery to maintain medication stability. The entire process from assessment to delivery typically takes 4-5 days, ensuring you receive genuine, properly stored prescription-only medicine with full clinical oversight and ongoing support throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro
Storage requirements represent a key practical difference when comparing Wegovy vs Mounjaro for real-world use. Wegovy offers superior travel flexibility with 6 weeks room temperature storage (below 30°C) once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both treatments require initial refrigeration at 2-8°C and use pre-filled injection pens for once-weekly administration. Wegovy's FlexTouch pen system provides dose accuracy and ease of use, whilst both treatments require commitment to the prescribed dose escalation schedule without skipping steps. The longer room temperature storage makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules, though both options accommodate most lifestyle requirements with proper planning.
Wegovy vs Mounjaro: Choosing Based on Individual Factors
The decision between Wegovy vs Mounjaro ultimately depends on individual clinical factors rather than a universal "best" option. Patients with previous GLP-1 experience might respond differently to Mounjaro's dual mechanism, whilst those seeking proven cardiovascular benefits might prefer Wegovy's SELECT trial data. Your prescriber will consider factors like diabetes status, previous weight loss attempts, medication tolerances, and lifestyle requirements when recommending between these approaches.
EverydayMeds' unique position as a supplier of both Wegovy and Mounjaro eliminates bias in treatment selection — our clinical team can objectively assess which option suits your circumstances. This comprehensive access means you won't need to compromise on treatment choice based on pharmacy availability. Both treatments require long-term commitment and lifestyle changes for sustained results, making the initial choice less important than ongoing adherence and clinical monitoring throughout your weight management journey.
Start Your Wegovy vs Mounjaro Assessment Today
Ready to explore which weight management option suits your needs? EverydayMeds provides access to both Wegovy and Mounjaro through our clinical assessment process, with transparent pricing and genuine medication assured. Use code FIRST40 for new customers or DOSE25 for returning patients — these discount codes apply at checkout to reach our published prices. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance and clinical oversight for both prescription-only medicines. Don't let the choice between Wegovy vs Mounjaro delay your weight management progress — our expert prescribers will help determine the most appropriate option based on your individual clinical profile. Begin your 3-minute assessment today and take the first step towards medically-supervised weight management with confidence and professional support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
